Please login to the form below

Not currently logged in
Email:
Password:

Emergency drug fund for cancer patients

The UK government has announced a £50m fund allowing patients access to cancer drugs up to six months earlier than would otherwise be possible

The UK government has announced a £50m fund aimed at giving patients access to cancer drugs recommended by a hospital doctor up to six months earlier than would otherwise be possible.

MPs have agreed to introduce the interim fund to pay for such medication, even if it has not been approved by the National Institute for Health and Clinical Excellence (NICE), from October 2010. It means cancer patients will be able to access new medication, available elsewhere in Europe, immediately to help extend or better the quality of their lives.

The move follows findings that Britain lags behind other countries when it comes to new drug provision, as well as pressure from campaigners who questioned why the fund that had been due to come in force in April 2010 could not be made available immediately.

The interim fund will be paid for from undisclosed savings in the health budget. Doctors and cancer specialists will decide how the fund is spent for their patients locally.

The announcement comes in the wake of Nikki Phelps' death, a terminally ill mother who had been denied NHS funding for life-prolonging drugs. Her case was raised by Prime Minister David Cameron during the election campaign after she said she was going to sell her house to pay for the drug. She died a week after the election.

Health Secretary Andrew Lansley said: "It's a scandal that we are strong in cancer research and participation in clinical trials in the UK, yet NHS patients aren't always seeing the benefits from the research swiftly enough.

"Patients should have access to innovative cancer drugs that can extend or improve their quality of life and which their doctors have recommended, which is why I'm determined to take action now."

27th July 2010

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics